Works by Fazio, Sergio
Results: 74
Liver Enzymes, Type 2 Diabetes, and Metabolic Syndrome in Middle-Aged, Urban Chinese Men.
- Published in:
- Metabolic Syndrome & Related Disorders, 2011, v. 9, n. 4, p. 305, doi. 10.1089/met.2011.0016
- By:
- Publication type:
- Article
Prevalence and Determinants of Hyperuricemia in Middle-Aged, Urban Chinese Men.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. 3, p. 263, doi. 10.1089/met.2009.0084
- By:
- Publication type:
- Article
Prevalence and Determinants of Metabolic Syndrome According to Three Definitions in Middle-Aged Chinese Men.
- Published in:
- Metabolic Syndrome & Related Disorders, 2009, v. 7, n. 1, p. 37, doi. 10.1089/met.2008.0042
- By:
- Publication type:
- Article
Aprospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States.
- Published in:
- Clinical Epidemiology, 2014, v. 6, p. 15, doi. 10.2147/CLEP.S53492
- By:
- Publication type:
- Article
A prospective study of statin use and mortality among 67,385 blacks and whites in the Southeastern United States.
- Published in:
- Clinical Epidemiology, 2013, v. 6, p. 15, doi. 10.2147/CLEP.S53492
- By:
- Publication type:
- Article
Brief Commentary: Marijuana and Cardiovascular Disease-What Should We Tell Patients?
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.
- Published in:
- Endocrine Reviews, 2019, v. 40, n. 2, p. 537, doi. 10.1210/er.2018-00184
- By:
- Publication type:
- Article
PMP22 Is Critical for Actin-Mediated Cellular Functions and for Establishing Lipid Rafts.
- Published in:
- Journal of Neuroscience, 2014, v. 34, n. 48, p. 16140, doi. 10.1523/JNEUROSCI.1908-14.2014
- By:
- Publication type:
- Article
Increased Cardiovascular Risk in Hypertriglyceridemic Patients With Statin-Controlled LDL Cholesterol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Threshold Effects of Circulating Angiopoietin-Like 3 Levels on Plasma Lipoproteins.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Extended-Release Niacin on New-Onset Diabetes Among Hyperlipidemic Patients Treated With Ezetimibe/Simvastatin in a Randomized Controlled Trial.
- Published in:
- Diabetes Care, 2012, v. 35, n. 4, p. 857, doi. 10.2337/dc11-1369
- By:
- Publication type:
- Article
Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 expression.
- Published in:
- Journal of Cellular Biochemistry, 2002, v. 86, n. 1, p. 56, doi. 10.1002/jcb.10190
- By:
- Publication type:
- Article
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
- Published in:
- Nature, 2007, v. 447, n. 7147, p. 959, doi. 10.1038/nature05844
- By:
- Publication type:
- Article
Correction: Ferri et al. Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review. J. Clin. Med. 2024, 13 , 943.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 943, doi. 10.3390/jcm13040943
- By:
- Publication type:
- Article
Is it Time to Enhance Assessment of Alcohol Intake in Patients Slated for Statin Therapy?
- Published in:
- Current Nutrition Reports, 2015, v. 4, n. 1, p. 1, doi. 10.1007/s13668-014-0107-1
- By:
- Publication type:
- Article
Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering.
- Published in:
- Cardiovascular Research, 2016, v. 112, n. 1, p. 429, doi. 10.1093/cvr/cvw194
- By:
- Publication type:
- Article
Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
- Published in:
- Cardiovascular Research, 2016, v. 110, n. 2, p. 268, doi. 10.1093/cvr/cvw053
- By:
- Publication type:
- Article
Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: another strike against the HDL dogma.
- Published in:
- 2009
- By:
- Publication type:
- commentary
Editorial: Sorting Out The Complexities of Reverse Cholesterol Transport: CETP Polymorphisms, HDL, and Coronary Disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2006, v. 91, n. 9, p. 3273, doi. 10.1210/jc.2006-1264
- By:
- Publication type:
- Article
Plasma lipid levels and colorectal adenoma risk.
- Published in:
- Cancer Causes & Control, 2015, v. 26, n. 4, p. 635, doi. 10.1007/s10552-015-0555-y
- By:
- Publication type:
- Article
Effect of proprotein convertase subtilisin/kexin type 9 inhibition on cancer events: A pooled, post hoc, competing risk analysis of alirocumab clinical trials.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 16, p. 16859, doi. 10.1002/cam4.6310
- By:
- Publication type:
- Article
Serum cholesterol and the risk of developing hormonally driven cancers: A narrative review.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6722, doi. 10.1002/cam4.5463
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 1, doi. 10.1111/dom.14053
- By:
- Publication type:
- Article
Cover Image, Volume 22, Issue 3.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 1, doi. 10.1111/dom.13998
- By:
- Publication type:
- Article
Risk of cardiovascular events in patients with hypertriglyceridaemia: A review of real‐world evidence.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 279, doi. 10.1111/dom.13921
- By:
- Publication type:
- Article
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin‐controlled LDL cholesterol.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 366, doi. 10.1111/dom.13537
- By:
- Publication type:
- Article
Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
- Published in:
- European Journal of Preventive Cardiology, 2021, v. 28, n. 8, p. 816, doi. 10.1177/2047487320915803
- By:
- Publication type:
- Article
Biologic bases of residual risk of cardiovascular events: A flawed concept.
- Published in:
- European Journal of Preventive Cardiology, 2018, v. 25, n. 16, p. 1831, doi. 10.1177/2047487318798060
- By:
- Publication type:
- Article
Uric acid correlates to oxidation and inflammation in opposite directions in women.
- Published in:
- Biomarkers, 2015, v. 20, n. 4, p. 225, doi. 10.3109/1354750X.2015.1068852
- By:
- Publication type:
- Article
Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.
- Published in:
- Kidney International, 2001, v. 59, n. 5, p. 1899, doi. 10.1046/j.1523-1755.2001.0590051899.x
- By:
- Publication type:
- Article
Transiently achieved very low low-density lipoprotein cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 16, p. 1408, doi. 10.1093/eurheartj/ehad144
- By:
- Publication type:
- Article
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.
- Published in:
- European Heart Journal, 2020, v. 41, n. 24, p. 2313, doi. 10.1093/eurheartj/ehz962
- By:
- Publication type:
- Article
Targeting PCSK9 for Therapeutic Gains.
- Published in:
- Current Atherosclerosis Reports, 2015, v. 17, n. 4, p. 1, doi. 10.1007/s11883-015-0499-4
- By:
- Publication type:
- Article
Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges.
- Published in:
- Current Atherosclerosis Reports, 2012, v. 14, n. 1, p. 1, doi. 10.1007/s11883-011-0219-7
- By:
- Publication type:
- Article
Insights into Atherosclerosis Using Nanotechnology.
- Published in:
- Current Atherosclerosis Reports, 2010, v. 12, n. 3, p. 209, doi. 10.1007/s11883-010-0106-7
- By:
- Publication type:
- Article
The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy.
- Published in:
- Current Atherosclerosis Reports, 2004, v. 6, n. 2, p. 148, doi. 10.1007/s11883-004-0104-8
- By:
- Publication type:
- Article
Re-emergence of fibrates in the management of dyslipidemia and cardiovascular risk.
- Published in:
- Current Atherosclerosis Reports, 2000, v. 2, n. 1, p. 29, doi. 10.1007/s11883-000-0092-2
- By:
- Publication type:
- Article
Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort.
- Published in:
- Journal of the Endocrine Society, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1210/jendso/bvz015
- By:
- Publication type:
- Article
Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2099, doi. 10.1002/art.39675
- By:
- Publication type:
- Article
Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Benzo[a]pyrene Potentiates the Pathogenesis of Abdominal Aortic Aneurysms in Apolipoprotein E Knockout Mice.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2012, v. 29, n. 1/2, p. 121, doi. 10.1159/000337593
- By:
- Publication type:
- Article
Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lack of macrophage fatty-acid?binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.
- Published in:
- Nature Medicine, 2001, v. 7, n. 6, p. 699, doi. 10.1038/89076
- By:
- Publication type:
- Article
Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice.
- Published in:
- Nephrology Dialysis Transplantation, 2011, v. 26, n. 8, p. 2491, doi. 10.1093/ndt/gfq759
- By:
- Publication type:
- Article
Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Sex-Specific Parental Effects on Offspring Lipid Levels.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Loss of SPRR3 in ApoE<sup>-/-</sup> mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0184620
- By:
- Publication type:
- Article
Medication‐based versus target‐based lipid management.
- Published in:
- Journal of Diabetes, 2018, v. 10, n. 10, p. 789, doi. 10.1111/1753-0407.12789
- By:
- Publication type:
- Article
PMP22 Regulates Cholesterol Trafficking and ABCA1-Mediated Cholesterol Efflux.
- Published in:
- Journal of Neuroscience, 2019, v. 39, n. 27, p. 5404, doi. 10.1523/jneurosci.2942-18.2019
- By:
- Publication type:
- Article